Target intelligence / Profile preview

Secretory processes in GI tract

Molecular classification
Other
01

Overview

Secretory processes in the GI tract refer to a complex set of coordinated mechanisms by which epithelial cells, enteroendocrine cells, immune cells, and neurons regulate the transport of ions (mainly chloride, bicarbonate, sodium, and potassium), water, enzymes, mucus, and hormones into the gut lumen. These processes are tightly regulated by numerous signaling molecules and receptors—including G protein-coupled receptors, chloride channels (notably the cystic fibrosis transmembrane conductance regulator, CFTR), and receptor tyrosine kinases—as well as by neuro-immune modulation and various GI hormones (such as gastrin, secretin, CCK, and more)[1][2][4]. Disruption or excessive activation of these pathways underlies major GI diseases such as secretory diarrhea and constipation and forms the basis for the therapeutic action of several modern drugs. This is not a singular molecular target and cannot be mapped to a unique receptor, ion channel, or transporter; it represents a physiological concept encompassing multiple proteins and signaling pathways[1][2][4][5].

Other names
Intestinal secretionGastrointestinal secretionGI tract secretory mechanismsIntestinal secretory pathways
02

Mechanism of action

- Modulation of chloride channel conductance (notably CFTR) - G protein-coupled receptor signaling (cAMP and Ca2+ mediated) - Inhibition or stimulation of neurotransmitter receptors (VIP, acetylcholine, histamine, prostaglandins)[1][2][3] - Activation or inhibition of hormone receptors (gastrin, somatostatin, secretin, CCK, GLP-1)[3][4]

03

Biological functions

Fluid and electrolyte transportEnzyme secretionMucus secretionSignal transduction
04

Disease associations

DiarrheaConstipationInfectious diseases of GI tractInflammatory diseases of GI tract
05

Safety considerations

Disrupted electrolyte/fluid balance (can cause dehydration or fluid overload)Side effects such as diarrhea or constipation with pharmacological modulationPotential worsening of underlying GI disorders
06

Interacting drugs

Lubiprostone (stimulates chloride channels for increased intestinal fluid; used in constipation)

3 more in the full profile.

07

Biomarkers

Fecal chlorideFecal sodium and water measurementIntestinal expression of CFTRLevels of GI hormones (e.g., gastrin, secretin, VIP)[1][4]

Beyond the preview

Go deeper on Secretory processes in GI tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secretory processes in GI tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call